檢索結果 - Lini Pandite

Refine Results
  1. 1
    Phase I Trial of Pazopanib in Patients with Advanced Cancer

    Phase I Trial of Pazopanib in Patients with Advanced Cancer 由 Herbert I. Hurwitz, Afshin Dowlati, Shermini Saini, S. Savage, A. Benjamin Suttle, D. Gibson, Jeffrey P. Hodge, Elmar M. Merkle, Lini Pandite

    出版 2009
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    High-dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission

    High-dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission 由 AS Freedman, JG Gribben, Donna Neuberg, P Mauch, RJ Soiffer, KC Anderson, Lini Pandite, MJ Robertson, Max Kroon, Jerome Ritz, LM Nadler

    出版 1996
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    Relationships between pazopanib exposure and clinical safety and efficacy in patients with advanced renal cell carcinoma

    Relationships between pazopanib exposure and clinical safety and efficacy in patients with advanced renal cell carcinoma 由 A. Benjamin Suttle, Howard Ball, Mathiéu Molimard, Thomas E. Hutson, Catherine L. Carpenter, Dilip Rajagopalan, Ying Lin, S. Swann, Rafael G. Amado, Lini Pandite

    出版 2014
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    Characterisation of liver chemistry abnormalities associated with pazopanib monotherapy: A systematic review and meta-analysis of clinical trials in advanced cancer patients

    Characterisation of liver chemistry abnormalities associated with pazopanib monotherapy: A systematic review and meta-analysis of clinical trials in advanced cancer patients 由 Thomas Powles, Sergio Bracarda, Chen Mei, Elliot Norry, Natalie Compton, Mark Heise, Thomas E. Hutson, Philipp Harter, Christopher L. Carpenter, Lini Pandite, Neil Kaplowitz

    出版 2015
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  5. 5
    Phase I and Pharmacokinetic Study of Lapatinib and Docetaxel in Patients With Advanced Cancer

    Phase I and Pharmacokinetic Study of Lapatinib and Docetaxel in Patients With Advanced Cancer 由 Patricia LoRusso, Suzanne F. Jones, Kevin M. Koch, Nikita Arya, Ronald A. Fleming, Jill Loftiss, Lini Pandite, Shirish M. Gadgeel, Barbara Weber, Howard A. Burris

    出版 2008
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    Cytokine and angiogenic factors associated with efficacy and toxicity of pazopanib in advanced soft-tissue sarcoma: an EORTC-STBSG study

    Cytokine and angiogenic factors associated with efficacy and toxicity of pazopanib in advanced soft-tissue sarcoma: an EORTC-STBSG study 由 Stefan Sleijfer, Thierry Gorlia, C. B. H. W. Lamers, Henry Burger, Jean‐Yves Blay, Axel Le Cesne, Michelle Scurr, F. Collin, Lini Pandite, Sandrine Marréaud, Peter Hohenberger

    出版 2012
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    The small-molecule VEGF receptor inhibitor pazopanib (GW786034B) targets both tumor and endothelial cells in multiple myeloma

    The small-molecule VEGF receptor inhibitor pazopanib (GW786034B) targets both tumor and endothelial cells in multiple myeloma 由 Klaus Podar, Giovanni Tonon, Martin Sattler, Yu‐Tzu Tai, Steven Le Gouill, Hiroshi Yasui, Kenji Ishitsuka, Shaji Kumar, Rakesh Kumar, Lini Pandite, Teru Hideshima, Dharminder Chauhan, Kenneth C. Anderson

    出版 2006
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    Phase I and Pharmacokinetic Study of Lapatinib in Combination With Capecitabine in Patients With Advanced Solid Malignancies

    Phase I and Pharmacokinetic Study of Lapatinib in Combination With Capecitabine in Patients With Advanced Solid Malignancies 由 Quincy Chu, Garry Schwartz, Johann S. de Bono, Deborah A. Smith, Kevin M. Koch, M. Versola, Lini Pandite, Nikita Arya, J. Curtright, Ronald A. Fleming, Peter Ho, Eric K. Rowinsky

    出版 2007
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    A Phase I and Pharmacokinetic Study of Oral Lapatinib Administered Once or Twice Daily in Patients with Solid Malignancies

    A Phase I and Pharmacokinetic Study of Oral Lapatinib Administered Once or Twice Daily in Patients with Solid Malignancies 由 Howard A. Burris, Charles W. Taylor, Suzanne F. Jones, Kevin M. Koch, M. Versola, Niki Arya, Ronald A. Fleming, Deborah A. Smith, Lini Pandite, Neil L. Spector, George Wilding

    出版 2009
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    Pazopanib-induced hyperbilirubinemia is associated with Gilbert's syndrome UGT1A1 polymorphism

    Pazopanib-induced hyperbilirubinemia is associated with Gilbert's syndrome UGT1A1 polymorphism 由 Chun‐Fang Xu, Brian H. Reck, Zhengyu Xue, Li Huang, Katherine L. Baker-Neblett, Mian Chen, E P Chen, Harma Ellens, Vincent Mooser, Lon R. Cardon, Colin F. Spraggs, Lini Pandite

    出版 2010
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  11. 11
    Pazopanib, a Multikinase Angiogenesis Inhibitor, in Patients With Relapsed or Refractory Advanced Soft Tissue Sarcoma: A Phase II Study From the European Organisation for Research and Treatment of Cancer–Soft Tissue and Bone Sarcoma Group (EORTC Study 62043)

    Pazopanib, a Multikinase Angiogenesis Inhibitor, in Patients With Relapsed or Refractory Advanced Soft Tissue Sarcoma: A Phase II Study From the European Organisation for Research... 由 Stefan Sleijfer, Isabelle Ray‐Coquard, Zsuzsa Pápai, Axel Le Cesne, Michelle Scurr, Patrick Schöffski, Françoise Collin, Lini Pandite, Sandrine Marréaud, Annick De Brauwer, M. van Glabbeke, Jaap Verweij, Jean‐Yves Blay

    出版 2009
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    First-in-human phase I trial of the bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein, SL-172154 in patients with platinum-resistant ovarian cancer

    First-in-human phase I trial of the bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein, SL-172154 in patients with platinum-resistant ovarian cancer 由 Nehal J. Lakhani, Daphne Stewart, Debra L. Richardson, Lauren Dockery, Linda Van Le, Justin Call, Fatima Rangwala, Guanfang Wang, Bo Ma, Simon Metenou, Jade Huguet, Elliot Offman, Lini Pandite, Erika Hamilton

    出版 2025
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  13. 13
    The Role of Aberrant VHL/HIF Pathway Elements in Predicting Clinical Outcome to Pazopanib Therapy in Patients with Metastatic Clear-Cell Renal Cell Carcinoma

    The Role of Aberrant VHL/HIF Pathway Elements in Predicting Clinical Outcome to Pazopanib Therapy in Patients with Metastatic Clear-Cell Renal Cell Carcinoma 由 Toni K. Choueiri, André P. Fay, Robert Gagnon, Ying Lin, Brittany Bahamón, Victoria E. Brown, Jonathan E. Rosenberg, Thomas E. Hutson, Katherine L. Baker-Neblett, Christopher L. Carpenter, Yuan Liu, Lini Pandite, Sabina Signoretti

    出版 2013
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    Correlation of PD-L1 Tumor Expression and Treatment Outcomes in Patients with Renal Cell Carcinoma Receiving Sunitinib or Pazopanib: Results from COMPARZ, a Randomized Controlled Trial

    Correlation of PD-L1 Tumor Expression and Treatment Outcomes in Patients with Renal Cell Carcinoma Receiving Sunitinib or Pazopanib: Results from COMPARZ, a Randomized Controlled T... 由 Toni K. Choueiri, David J. Figueroa, André P. Fay, Sabina Signoretti, Yuan Liu, Robert Gagnon, Keith C. Deen, Christopher Carpenter, Peter Benson, Thai H. Ho, Lini Pandite, Paul de Souza, Thomas Powles, Robert J. Motzer

    出版 2014
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    Phase I Dose Escalation and Pharmacokinetic Study of Lapatinib in Combination With Trastuzumab in Patients With Advanced ErbB2-Positive Breast Cancer

    Phase I Dose Escalation and Pharmacokinetic Study of Lapatinib in Combination With Trastuzumab in Patients With Advanced ErbB2-Positive Breast Cancer 由 Anna Maria Storniolo, Mark D. Pegram, Beth Overmoyer, Paula Silverman, N. W. Peacock, Suzanne F. Jones, Jill Loftiss, Nikita Arya, Kevin M. Koch, Elaine Paul, Lini Pandite, Ronald A. Fleming, Peter F. Lebowitz, Peter Ho, Howard A. Burris

    出版 2008
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial

    Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial 由 Cora N. Sternberg, Ian D. Davis, Jozef Mardiak, Cezary Szczylik, Eunsik Lee, John Wagstaff, Carlos H. Barrios, Pamela Salman, Oleg Gladkov, Alexander Kavina, Juan José Zarbá, Chen Mei, Lauren McCann, Lini Pandite, Debasish Roychowdhury, Robert E. Hawkins

    出版 2010
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    Pazopanib Efficacy in Renal Cell Carcinoma: Evidence for Predictive Genetic Markers in Angiogenesis-Related and Exposure-Related Genes

    Pazopanib Efficacy in Renal Cell Carcinoma: Evidence for Predictive Genetic Markers in Angiogenesis-Related and Exposure-Related Genes 由 Chun‐Fang Xu, Nan Bing, Howard Ball, Dilip Rajagopalan, Cora N. Sternberg, Thomas E. Hutson, Paul de Souza, Zhengyu G. Xue, Lauren McCann, Karen S. King, Leigh Ragone, John C. Whittaker, Colin F. Spraggs, Lon R. Cardon, Vincent Mooser, Lini Pandite

    出版 2011
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  18. 18
    <i>HLA-B</i>*57:01 Confers Susceptibility to Pazopanib-Associated Liver Injury in Patients with Cancer

    <i>HLA-B</i>*57:01 Confers Susceptibility to Pazopanib-Associated Liver Injury in Patients with Cancer 由 Chun‐Fang Xu, Toby Johnson, Xiaojing Wang, Chris Carpenter, Alan P. Graves, Liling Warren, Zhengyu Xue, Karen S. King, Dana J. Fraser, Sandy Stinnett, Linda P. Briley, Ionel Mitrica, Colin F. Spraggs, Matthew R. Nelson, Hiroomi Tada, Andreas du Bois, Thomas Powles, Neil Kaplowitz, Lini Pandite

    出版 2015
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  19. 19
    Dabrafenib in patients with BRAFV600E-positive advanced non-small-cell lung cancer: a single-arm, multicentre, open-label, phase 2 trial

    Dabrafenib in patients with BRAFV600E-positive advanced non-small-cell lung cancer: a single-arm, multicentre, open-label, phase 2 trial 由 David Planchard, Tae Min Kim, Julien Mazières, Élisabeth Quoix, Gregory J. Riely, Fabrice Barlési, Pierre‐Jean Souquet, Egbert F. Smit, Harry J.M. Groen, Ronan J. Kelly, Byoung Chul Cho, Mark A. Socinski, Lini Pandite, Christine Nase, Bo Ma, Anthony M. D’Amelio, Bijoyesh Mookerjee, C. Martin Curtis, Bruce E. Johnson

    出版 2016
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  20. 20
    Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma

    Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma 由 Robert J. Motzer, Thomas E. Hutson, David Cella, James A. Reeves, Robert D. Hawkins, Jun Guo, Paul Nathan, Michael Staehler, Paul de Souza, Jaime R. Merchan, Ekaterini Boleti, Kate Fife, Jie Jin, Robert J. Jones, Hirotsugu Uemura, Ugo De Giorgi, Ulrika Harmenberg, Jinwan Wang, Cora N. Sternberg, Keith C. Deen, Lauren McCann, Michelle D. Hackshaw, Rocco J. Crescenzo, Lini Pandite, Toni K. Choueiri

    出版 2013
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: